These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16760530)

  • 21. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection and risk behaviour of commercial sex workers and intravenous drug users in Slovakia.
    Staneková D; Jiresová K; Habeková M; Wimmerová S; Cuitti M; Vavrincíková L; Valachovicová M; Kovacic V; Mayer V
    Cent Eur J Public Health; 2004 Dec; 12(4):197-200. PubMed ID: 15666457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users.
    Miller CL; Johnston C; Spittal PM; Li K; Laliberté N; Montaner JS; Schechter MT
    Hepatology; 2002 Sep; 36(3):737-42. PubMed ID: 12198668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
    Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
    Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and seroprevalence of hepatitis C virus antibody among blood donors in Lagos.
    Balogun TM; Akinsete I; Durosinmi MA
    Niger Postgrad Med J; 2012 Mar; 19(1):36-9. PubMed ID: 22430600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
    Hahn JA; Page-Shafer K; Lum PJ; Bourgois P; Stein E; Evans JL; Busch MP; Tobler LH; Phelps B; Moss AR
    J Infect Dis; 2002 Dec; 186(11):1558-64. PubMed ID: 12447730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of hepatitis C infection among injection drug users in Mizoram, India.
    Chelleng PK; Borkakoty BJ; Chetia M; Das HK; Mahanta J
    Indian J Med Res; 2008 Nov; 128(5):640-6. PubMed ID: 19179686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center.
    Sivapalasingam S; Malak SF; Sullivan JF; Lorch J; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2002 Jun; 23(6):319-24. PubMed ID: 12083235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for hepatitis C virus seropositivity in heterosexual couples.
    Osmond DH; Padian NS; Sheppard HW; Glass S; Shiboski SC; Reingold A
    JAMA; 1993 Jan; 269(3):361-5. PubMed ID: 8418342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
    Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
    Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
    Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
    Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nationwide seroepidemiology of hepatitis C virus infection in South Korea.
    Kim DY; Kim IH; Jeong SH; Cho YK; Lee JH; Jin YJ; Lee D; Suh DJ; Han KH; Park NH; Kang HY; Jung YK; Kim YS; Kim KA; Lee YJ; Lee BS; Yim HJ; Lee HJ; Baik SK; Tak WY; Lee SJ; Chung WJ; Choi SK; Cho EY; Heo J; Kim DJ; Song BC; Kim MW; Lee J; Chae HB; Choi DH; Choi HY; Ki M
    Liver Int; 2013 Apr; 33(4):586-94. PubMed ID: 23356674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria.
    Othman BM; Monem FS
    Saudi Med J; 2002 Apr; 23(4):393-5. PubMed ID: 11953762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of hepatitis C virus (HCV) in health care workers of a tertiary care centre in New Delhi.
    Jindal N; Jindal M; Jilani N; Kar P
    Indian J Med Res; 2006 Feb; 123(2):179-80. PubMed ID: 16575118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.